Dr. Michael Thirman, MD

Dr. Michael Thirman, MD

Work:

Co-Program Leader, University of Chicago Medicine Comprehensive Cancer Center

Education:

Doctor of Medicine, University of Michigan Medical School

Dr. Michael J. Thirman has over 28 years of experience in the field of Hematology and Oncology. He earned his BA in Biomedical Sciences from the University of Michigan and his MD from the University of Michigan Medical School. After completing his residency in Internal Medicine at M Health Fairview University of Minnesota Medical Center - West Bank Hospital, he went on to complete a fellowship in Clinical Pharmacology at Minneapolis VA Medical Center and in Hematology and Oncology at University of Chicago Medical Center. Today, this expert is board certified in Internal Medicine. Formerly, this expert held roles as an Assistant Professor of the Section of Hematology/Oncology at the University of Chicago and as the Co-Program Leader of Hematopoiesis and Hematologic Malignancies at the University of Chicago Comprehensive Cancer Center. Currently, he serves as a Physician at UChicago Medicine Duchossois Center for Advanced Medicine and as an Associate Professor of Medicine at the University of Chicago. He also serves as the Director of Leukemia Biology at the University of Chicago.

email icon

m*********@u*****.edu

phone icon

(773) ***-****

location icon

Wilmette, Illinois

At a Glance

Expert Witness Activity

17

Plaintiff Cases

lock icon

Defense Cases

15

Expert Challenges

3

Deposition Transcripts

lock icon

Publications

85

Media & News

152

Social Media Mentions

lock icon

Expert Institute operates independently and objectively as an expert witness data provider. Expert witness profiling focuses on individuals involved in publicly disclosed litigation. Expert Institute does not employ, endorse, or suggest an affiliation with any individuals for whom data is available.

Litigation Activities

18 records available

Case Name

Role

Filed Date

Kevin Wright vs Union Oil Company of California, et al.

Expert Witness

2021-03-08

Celegene Corporation v. Apotex, Inc.

Expert Witness

2019-02-26

Acrotech Biopharma, LLC, et al. v. Fresenius Kabi USA, LLC, et al.

Expert Witness

2018-10-03

green checkmark

Unlock Dr. Michael Thirman, MD's full profile

See their litigation activity, risk and credibility history

Litigation Analytics

Retained By

Defense

Plaintiff

Other

Activity over time

0

25

50

75

100

2000

0

2002

0

2004

0

2006

0

2008

0

2010

0

Area of Law

2001-2009

2001-2009

2001-2009

2001-2009

2001-2009

2001-2009

2001-2009

2001-2019

0

25

50

75

100

Activity by state

Map of USA

Case Outcome

0

25

50

75

100

Unlock Dr. Michael Thirman, MD's full profile

See their litigation activity, risk and credibility history

Publications

85 records available

Title

Type

Apoptosis Induction and Growth Suppression By U19/Eaf2 Is Mediated Through Its ELL-Binding Domain

Journal Article

Clinical and Molecular Response of AML Harboring Non-Canonical FLT3 N676k Driver Mutations to Contemporary FLT3 Inhibitors

Journal Article

Molecular Genetics of Acute Myeloid Leukemia

Practice Guideline

green checkmark

Unlock Dr. Michael Thirman, MD's full profile

See their litigation activity, risk and credibility history

5 stars

Using Expert Radar, we uncovered a textbook chapter written by the opposing expert that contradicted his testimony, helping us secure a $44 million verdict—the largest single verdict for a single plaintiff in Kentucky's history.

Mark Alcott, Esq.

Harlin Parker

Media & News

152 records available

Title

Description

Clinical Trial Will Evaluate Novel 3-Drug Regimen for First- ...

Mar 4, 2024 -- Cancer specialists want to know whether combining these 3 agents can lead to greater efficacy in the treatment of patients with CLL. This ...

Comprehensive care improves outcomes in adult ...

Jan 16, 2024 -- A new study shows that comprehensive treatment of acute lymphoblastic leukemia improves outcomes and reduces the negative impact of ...

Nearly 200 UChicago Medicine physicians named to ...

Jan 11, 2024 -- Michael J. Thirman, MD. Hospice and Palliative Medicine. Monica ... Monica Catherine Malec, MD. Infectious Disease. Stephen Weber, MD. Pain ...

green checkmark

Unlock Dr. Michael Thirman, MD's full profile

See their litigation activity, risk and credibility history

Education

Institution

Degree Type

University of Michigan Medical School

Doctor of Medicine

University of Michigan

Bachelor of Arts

Work History

Title

Employer

Co-Program Leader

University of Chicago Medicine Comprehensive Cancer Center

Director

University of Chicago Medicine

Associate Professor of Medicine

University of Chicago Medicine

Get critical intel on Dr. Michael Thirman, MD

lock icon

Contradictory statements in testimony

lock icon

Misrepresentations in CVs, online profiles / bios, LinkedIn

lock icon

Biases in expert witness experience

lock icon

Financial ties with organizations they represent

Related Experts